Direxion Daily S&P Biotech Bear 3X ETF
LABD
15 hedge funds and large institutions have $28.7M invested in Direxion Daily S&P Biotech Bear 3X ETF in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 5 increasing their positions, 6 reducing their positions, and 5 closing their positions.
418% more call options, than puts
Call options by funds: $7.72M | Put options by funds: $1.49M
58% more capital invested
Capital invested by funds: $18.1M → $28.7M (+$10.6M)
18.59% more ownership
Funds ownership: 18.83% → 37.42% (+19%)
12% less funds holding
Funds holding: 17 → 15 (-2)
17% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 6
40% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$12.7M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$5.77M |
| 3 |
Squarepoint
New York
|
+$530K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$359K |
| 5 |
GS
GTS Securities
Miami,
Florida
|
+$225K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$1.78M |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.2M |
| 3 |
TSS
Two Sigma Securities
New York
|
-$882K |
| 4 |
Jane Street
New York
|
-$743K |
| 5 |
QC
Quadrature Capital
London,
United Kingdom
|
-$253K |
LABD Hedge Fund Activity: Q3 2024 in Review
15 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily S&P Biotech Bear 3X ETF (LABD) for Q3 2024, worth a combined $28.7M — up 58% from $18.1M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of LABD and 3 opened new positions — a net loss of 2 holders — while 6 trimmed existing stakes and 5 added.
The largest buyer was HRT Financial, adding an estimated $12.7M. The largest seller was Virtu Financial, cutting an estimated $1.78M.
- 15 institutional investors held Direxion Daily S&P Biotech Bear 3X ETF (LABD) as of Q3 2024, down from 17 in Q2 2024.
- Funds reported $28.7M of Direxion Daily S&P Biotech Bear 3X ETF stock for Q3 2024, up 58% quarter-over-quarter.
- 3 funds opened new Direxion Daily S&P Biotech Bear 3X ETF positions in Q3 2024 and 5 closed out, a net change of -2 holders.
- The largest Direxion Daily S&P Biotech Bear 3X ETF buyer in Q3 2024 was HRT Financial, an estimated $12.7M added.
- The largest Direxion Daily S&P Biotech Bear 3X ETF seller in Q3 2024 was Virtu Financial, an estimated $1.78M sold.
Based on aggregated 13F filings for Q3 2024.